Format

Send to

Choose Destination
JAMA. 2015 Oct 27;314(16):1687-8. doi: 10.1001/jama.2015.11845.

Experience With the Priority Review Voucher Program for Drug Development.

Author information

1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Boston, Massachusetts.
PMID:
26414802
DOI:
10.1001/jama.2015.11845
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center